Table 4. Standardised incidence ratios comparing childhood cancer incidence rates in the offspring of RTs to SEER and Connecticut registry rates (n=100 115)a.
Offspring of females
|
Offspring of males
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Males
|
Females
|
Males
|
Females
|
|||||||||
O | E | O/E (95% CI) | O | E | O/E (95% CI) | O | E | O/E (95% CI) | O | E | O/E (95% CI) | |
SEER registry comparison | ||||||||||||
Leukaemia | 37 | 30 | 1.2 (0.9–1.7) | 26 | 24 | 1.1 (0.7–1.6) | 11 | 9 | 1.3 (0.6–2.2) | 8 | 7 | 1.2 (0.5–2.4) |
Lymphoma | 33 | 20 | 1.7b (1.2–2.4) | 14 | 14 | 1.0 (0.6–1.7) | 10 | 6 | 1.7 (0.8–3.1) | 3 | 4 | 0.8 (0.2–2.2) |
All sites | 120 | 114 | 1.1 (0.9–1.3) | 101 | 99 | 1.0 (0.8–1.2) | 39 | 33 | 1.2 (0.8–1.6) | 24 | 29 | 0.9 (0.5–1.3) |
Connecticut registry comparison | ||||||||||||
Leukaemia | 37 | 32 | 1.2 (0.8–1.6) | 26 | 24 | 1.1 (0.7–1.6) | 11 | 9 | 1.2 (0.6–2.1) | 8 | 7 | 1.2 (0.5–2.3) |
Lymphoma | 33 | 21 | 1.6b (1.1–2.2) | 14 | 14 | 1.0 (0.5–1.7) | 10 | 6 | 1.6 (0.8–2.9) | 3 | 4 | 0.7 (0.2–2.1) |
All sites | 120 | 113 | 1.1 (0.9–1.3) | 101 | 99 | 1.0 (0.8–1.2) | 41 | 36 | 1.1 (0.8–1.5) | 24 | 28 | 0.9 (0.6–1.3) |
E=expected; O=observed; RT=radiologic technologist; SEER=Surveillance Epidemiology and End Results.
Excludes data on 5826 subjects with missing gender or whose parent reported a race other than white.
P<0.05.